These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

206 related articles for article (PubMed ID: 30625345)

  • 21. G-Protein-coupled receptors as potential drug candidates in preeclampsia: targeting the relaxin/insulin-like family peptide receptor 1 for treatment and prevention.
    Conrad KP
    Hum Reprod Update; 2016 Sep; 22(5):647-64. PubMed ID: 27385360
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Relaxin inhibits cardiac fibrosis and endothelial-mesenchymal transition via the Notch pathway.
    Zhou X; Chen X; Cai JJ; Chen LZ; Gong YS; Wang LX; Gao Z; Zhang HQ; Huang WJ; Zhou H
    Drug Des Devel Ther; 2015; 9():4599-611. PubMed ID: 26316699
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Serelaxin as a novel therapeutic opposing fibrosis and contraction in lung diseases.
    Lam M; Royce SG; Samuel CS; Bourke JE
    Pharmacol Ther; 2018 Jul; 187():61-70. PubMed ID: 29447958
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Site-related Effects of Relaxin in the Gastrointestinal Tract Through Nitric Oxide Signalling: An Updated Report.
    Garella R; Squecco R; Baccari MC
    Curr Protein Pept Sci; 2017; 18(12):1254-1262. PubMed ID: 28606038
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Relaxin-a pleiotropic hormone and its emerging role for experimental and clinical therapeutics.
    Dschietzig T; Bartsch C; Baumann G; Stangl K
    Pharmacol Ther; 2006 Oct; 112(1):38-56. PubMed ID: 16647137
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Human Recombinant Relaxin (Serelaxin) as Anti-fibrotic Agent: Pharmacology, Limitations and Actual Perspectives.
    Sassoli C; Nistri S; Chellini F; Bani D
    Curr Mol Med; 2022; 22(3):196-208. PubMed ID: 33687895
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The physiological effects of relaxin during pregnancy: studies in rats and pigs.
    Sherwood OD; Downing SJ; Guico-Lamm ML; Hwang JJ; O'Day-Bowman MB; Fields PA
    Oxf Rev Reprod Biol; 1993; 15():143-89. PubMed ID: 8336976
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Prevention of bleomycin-induced pulmonary fibrosis by a novel antifibrotic peptide with relaxin-like activity.
    Pini A; Shemesh R; Samuel CS; Bathgate RA; Zauberman A; Hermesh C; Wool A; Bani D; Rotman G
    J Pharmacol Exp Ther; 2010 Dec; 335(3):589-99. PubMed ID: 20826567
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Characterizing relaxin receptor expression and exploring relaxin's effect on tissue remodeling/fibrosis in the human bladder.
    Diaz EC; Briggs M; Wen Y; Zhuang G; Wallace SL; Dobberfuhl AD; Kao CS; Chen BC
    BMC Urol; 2020 Apr; 20(1):44. PubMed ID: 32321501
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Relaxin and the Cardiovascular System: from Basic Science to Clinical Practice.
    Martins RC; Pintalhão M; Leite-Moreira A; Castro-Chaves P
    Curr Mol Med; 2020; 20(3):167-184. PubMed ID: 31642776
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Relaxin suppresses atrial fibrillation, reverses fibrosis and reduces inflammation in aged hearts.
    Romero G; Martin B; Gabris B; Salama G
    Biochem Pharmacol; 2024 Sep; 227():116407. PubMed ID: 38969298
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The single-chain relaxin mimetic, B7-33, maintains the cardioprotective effects of relaxin and more rapidly reduces left ventricular fibrosis compared to perindopril in an experimental model of cardiomyopathy.
    Alam F; Gaspari TA; Kemp-Harper BK; Low E; Aw A; Ferens D; Spizzo I; Jefferis AM; Praveen P; Widdop RE; Bathgate RAD; Hossain MA; Samuel CS
    Biomed Pharmacother; 2023 Apr; 160():114370. PubMed ID: 36753958
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A single-chain derivative of the relaxin hormone is a functionally selective agonist of the G protein-coupled receptor, RXFP1.
    Hossain MA; Kocan M; Yao ST; Royce SG; Nair VB; Siwek C; Patil NA; Harrison IP; Rosengren KJ; Selemidis S; Summers RJ; Wade JD; Bathgate RAD; Samuel CS
    Chem Sci; 2016 Jun; 7(6):3805-3819. PubMed ID: 30155023
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Relaxin as a treatment for musculoskeletal fibrosis: What we know and future directions.
    Nourmahnad A; Javad Shariyate M; Khak M; Grinstaff MW; Nazarian A; Rodriguez EK
    Biochem Pharmacol; 2024 Jul; 225():116273. PubMed ID: 38729446
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Relaxin: a new approach for the treatment of acute congestive heart failure.
    Grossman J; Frishman WH
    Cardiol Rev; 2010; 18(6):305-12. PubMed ID: 20926940
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Synthetic short-chain peptide analogues of H1 relaxin lack affinity for the RXFP1 receptor and relaxin-like bioactivity. Clues to a better understanding of relaxin agonist design.
    D'Ercole A; Nistri S; Pacini L; Carotenuto A; Santoro F; Papini AM; Bathgate RAD; Bani D; Rovero P
    Front Pharmacol; 2022; 13():942178. PubMed ID: 36034864
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Role of protein kinase C β₂ in relaxin-mediated inhibition of cardiac fibrosis.
    Su W; Wang P; Chen H; Li H
    J Endocrinol Invest; 2014 Jun; 37(6):559-64. PubMed ID: 24729283
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The effects of relaxin on extracellular matrix remodeling in health and fibrotic disease.
    Samuel CS; Lekgabe ED; Mookerjee I
    Adv Exp Med Biol; 2007; 612():88-103. PubMed ID: 18161483
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Relaxin and nitric oxide signalling.
    Baccari MC; Bani D
    Curr Protein Pept Sci; 2008 Dec; 9(6):638-45. PubMed ID: 19075752
    [TBL] [Abstract][Full Text] [Related]  

  • 40. H3 Relaxin Protects Against Myocardial Injury in Experimental Diabetic Cardiomyopathy by Inhibiting Myocardial Apoptosis, Fibrosis and Inflammation.
    Zhang X; Pan L; Yang K; Fu Y; Liu Y; Chi J; Zhang X; Hong S; Ma X; Yin X
    Cell Physiol Biochem; 2017; 43(4):1311-1324. PubMed ID: 28992627
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.